Optimize
Healthcare Decisions with TreeAge Pro Software
Clinicians, policymakers and others use TreeAge software to
make complex healthcare decisions. When multiple treatment options
are available, and outcomes are uncertain, our decision analysis software
can help you present options, specify risks and analyze the effects
of uncertainty - particularly when it is important to consider both
the costs of available strategies and the value placed on particular
health outcomes.
In an era of limited resources and growing demands on healthcare
spending, many public health researchers and pharmaco-economists
are using TreeAge software to develop cost-effective strategies
and therapies. Our healthcare tools let you model treatment protocols,
immunization programs, diagnostic testing and pharmaceutical R&D
projects and then analyze these complex decisions on the basis of
a single criterion (e.g., life expectancy or patient utility) or
multiple criteria (e.g., cost-effectiveness or cost-utility).
TreeAge Pro
Healthcare Offers Cost-Effectiveness Analysis … And More
TreeAge Pro Healthcare lets you analyze models on the basis
of expected costs, expected effectiveness or combined cost-effectiveness,
and automatically generates graphs and reports including marginal
cost, marginal effectiveness and marginal cost-effectiveness information.
Instances of absolute or extended dominance (including parameters)
are identified both graphically and in text reports. Powerful sensitivity
analysis can be carried out in cost-effectiveness models.
To go beyond expected value information, TreeAge Pro Healthcare
offers extensive Monte Carlo simulation capabilities. Markov processes
are graphically displayed with nodes to identify all of the potential
states and the potential state transitions. The software also includes
tunnel states and the ability to define tables which specify state
transition probabilities for any stage during the Markov model analysis.
Other features of particular interest to the medical and pharmaceutical
communities include:
- Built-in Markov analysis-related functions such as declining
exponential approximation of life expectancy ("DEALE")
- Conversion of mortality rates into probability of death
- Discounted utilities, and many parameterized distributions
- Implementation of Bayes' revision to convert test/procedure
sensitivity and specificity values into meaningful decision probabilities
- A table interface allowing the entry of mortality or other
Markov analysis-related tables for use in any number of trees
Healthcare
and pharmaceutical professionals turn to TreeAge Pro Healthcare
When it comes to decision analysis software, TreeAge Pro
Healthcare is the industry standard.
Here are just a few of the hundreds of professionals who use our
TreeAge software to facilitate healthcare and pharmaceutical research:
Dr. Victor Grann, Clinical Professor of Medicine and Public Health
at Columbia University's School of Public Health, has used TreeAge
Pro software to model and analyze the effects of prophylactic treatments
on patients who have tested positive for certain genetic risk factors.
The resulting information is helping patients, care givers and health
management organizations weigh the risks, costs and benefits of
alternative treatment decisions.
Learn more about Grann's use of TreeAge Healthcare. >
George Papadopoulos, Director of Health Economics and Pricing at
Johnson & Johnson Pharmaceutical Services, uses TreeAge Pro
Healthcare's cost-effectiveness features to demonstrate the value
of new pharmaceutical products and set pricing.
Learn
more about how Johnson & Johnson's strategic marketing group
uses TreeAge software. >
Researcher Ralph Crott used TreeAge Pro Healthcare to evaluate
the cost effectiveness of alternative approaches to managing dyspepsia
- building a decision tree with 6,000+ nodes to compare treatment
strategies based on cost and efficiency.
Learn
more about Crott's research. >
Learn
more about TreeAge Pro Healthcare. >
Learn
more about the TreeAge Pro Suite. >